SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

Abstract Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018-12-01
Colecção:Journal for ImmunoTherapy of Cancer
Assuntos:
Biomarkers
Cancer immunotherapy
PD-1/PD-L1
Checkpoint inhibitor
Acesso em linha:http://link.springer.com/article/10.1186/s40425-018-0453-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados